Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Recommendation of “Hold” from Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has been assigned an average recommendation of “Hold” from the four ratings firms that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $4.00.

Several equities analysts recently commented on BIOX shares. Weiss Ratings upgraded Bioceres Crop Solutions from a “sell (d-)” rating to a “sell (d)” rating in a research report on Friday, June 26th. Wall Street Zen downgraded Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research report on Saturday, April 4th.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds have recently bought and sold shares of the stock. Jones Financial Companies Lllp grew its stake in Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after buying an additional 5,339 shares in the last quarter. Bank of America Corp DE lifted its holdings in shares of Bioceres Crop Solutions by 186.7% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after acquiring an additional 3,735 shares during the last quarter. Virtu Financial LLC purchased a new position in Bioceres Crop Solutions in the third quarter worth $40,000. Invesco Ltd. purchased a new position in Bioceres Crop Solutions in the fourth quarter worth $45,000. Finally, PDT Partners LLC increased its stake in Bioceres Crop Solutions by 58.9% in the second quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock valued at $126,000 after acquiring an additional 10,449 shares during the last quarter. 17.68% of the stock is currently owned by institutional investors.

Bioceres Crop Solutions Price Performance

NASDAQ:BIOX remained flat at $0.33 during trading hours on Friday. 111,171 shares of the company’s stock traded hands, compared to its average volume of 231,477. The business’s 50 day moving average price is $0.43 and its 200 day moving average price is $0.69. The stock has a market cap of $20.93 million, a price-to-earnings ratio of -0.09 and a beta of 0.42. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.88 and a quick ratio of 0.70. Bioceres Crop Solutions has a 1 year low of $0.31 and a 1 year high of $5.00.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, May 11th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.11). Bioceres Crop Solutions had a negative return on equity of 33.97% and a negative net margin of 92.85%.The firm had revenue of $39.40 million during the quarter, compared to the consensus estimate of $54.50 million. Equities research analysts anticipate that Bioceres Crop Solutions will post -0.16 earnings per share for the current year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.